Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson’s Disease Susceptibility

Molecular Neurobiology

Volumn 53, Issue 7, 2016, Pages 4931-4938

  Liu, Guiyou ^a   Liu, Yongquan ^b   Jiang, Qinghua ^c   Jiang, Yongshuai ^d   Feng, Rennan ^d   Zhang, Liangcai ^e   Chen, Zugen ^f   Li, Keshen ^g,h   Liu, Jiafeng ^b  

^a Chinese Academy of Sciences   (China)

^b First Hospital of Harbin   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

^e Rice University   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GUANGDONG MEDICAL UNIVERSITY   (China)

^h JINAN UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Genome wide association study; Parkinson s disease; rs75932628; TREM2

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIATION; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PARKINSON DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; TREM2 GENE; UPREGULATION; BIOSYNTHESIS; CASE CONTROL STUDY; EUROPE; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; METABOLISM;

CASE-CONTROL STUDIES; DATABASES, GENETIC; EUROPE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MEMBRANE GLYCOPROTEINS; PARKINSON DISEASE; RECEPTORS, IMMUNOLOGIC;

EID: 84941366394     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9416-7     Document Type: Article

References (31)

1. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J et al (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368:107–116
2. Lill CM, Rengmark A, Pihlstrom L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T et al (2015) The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. Alzheimers Dement
3. Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C et al (2013) TREM2 in neurodegeneration: evidence for association of the p.R47h variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener 8:19
4. Benitez BA, Cruchaga C (2013) TREM2 and neurodegenerative disease. N Engl J Med 369:1567–1568
5. Jonsson T, Stefansson K (2013) TREM2 and neurodegenerative disease. N Engl J Med 369:1568–1569
6. Rothwell PM (2005) Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365:176–186
7. Liu G, Li F, Zhang S, Jiang Y, Ma G, Shang H, Liu J, Feng R et al. Analyzing large-scale samples confirms the association between the abca7 rs3764650 polymorphism and alzheimer's disease susceptibility. Mol Neurobiol 2014
8. Chen H, Wu G, Jiang Y, Feng R, Liao M, Zhang L, Ma G, Chen Z et al (2014) Analyzing 54,936 samples supports the association between cd2ap rs9349407 polymorphism and Alzheimer's disease susceptibility. Mol Neurobiol
9. Liu G, Zhang S, Cai Z, Ma G, Zhang L, Jiang Y, Feng R, Liao M et al (2013) PICALM gene rs3851179 polymorphism contributes to Alzheimer's disease in an Asian population. Neuromolecular Med 15:384–388
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
11. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
12. Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046–1055
13. Song F, Khan KS, Dinnes J, Sutton AJ (2002) Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31:88–95
14. Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 46:989–993
15. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E et al (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet 8:e1002548
16. Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN et al (2012) Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet 8:e1002707
17. Dumitriu A, Latourelle JC, Hadzi TC, Pankratz N, Garza D, Miller JP, Vance JM, Foroud T et al (2012) Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genet 8:e1002794
18. Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC et al (2014) Missense variant in TREML2 protects against Alzheimer's disease. Neurobiol Aging 35:1510 e1519–1526
19. Replogle JM, Chan G, White CC, Raj T, Winn PA, Evans DA, Sperling RA, Chibnik LB et al (2015) A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol 77:469–477
20. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45:1452–1458
21. Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V (2014) The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia. Alzheimers Dement
22. Lue LF, Schmitz CT, Serrano G, Sue LI, Beach TG, Walker DG (2014) Trem2 protein expression changes correlate with Alzheimer's disease neurodegenerative pathologies in post-mortem temporal cortices. Brain Pathol
23. Hu N, Tan MS, Yu JT, Sun L, Tan L, Wang YL, Jiang T (2014) Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. J Alzheimers Dis 38:497–501
24. Strobel S, Grunblatt E, Riederer P, Heinsen H, Arzberger T, Al-Sarraj S, Troakes C, Ferrer I et al (2015) Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARgamma. J Neural Transm
25. Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, Baloh RH, Ravits J et al (2014) TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 71:449–453
26. Feng SJ, Nie K, Gan R, Huang J, Zhang YW, Wang LM, Zhao JH, Tang HM et al (1780) Triggering receptor expressed on myeloid cells 2 variants are rare in Parkinson's disease in a Han Chinese cohort. Neurobiol Aging 2014(35):e1711–1782
27. Chen Y, Chen X, Guo X, Song W, Cao B, Wei Q, Ou R, Zhao B et al (2015) Assessment of TREM2 rs75932628 association with Parkinson's disease and multiple system atrophy in a Chinese population. Neurol Sci
28. Lin WY, Lou XY, Gao G, Liu N (2014) Rare variant association testing by adaptive combination of p-values. PLoS One 9:e85728
29. Clarke GM, Rivas MA, Morris AP (2013) A flexible approach for the analysis of rare variants allowing for a mixture of effects on binary or quantitative traits. PLoS Genet 9:e1003694
30. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X (2011) Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89:82–93
31. Yang J, Lee SH, Goddard ME, Visscher PM (2011) GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88:76–82